PCM
ETON icon

Prelude Capital Management’s Eton Pharmaceutcials ETON Stock Holding History

Prelude Capital Management’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.66M Buy
188,802
+143,477
+317% +$2.51M 0.36% 58
2025
Q4 		$766K Buy
45,325
+3,452
+8% +$60.7K 0.06% 384
2025
Q3 		$910K Sell
41,873
-1,727
-4% -$28.7K 0.07% 329
2025
Q2 		$621K Sell
43,600
-125,836
-74% -$1.99M 0.06% 381
2025
Q1 		$2.2M Buy
169,436
+145,194
+599% +$2.19M 0.17% 141
2024
Q4 		$323K Buy
+24,242
New +$246K 0.02% 770
2021
Q2 		– Sell
-30,905
Closed -$226K – 1719
2021
Q1 		$226K Sell
30,905
-1,056
-3% -$9.01K 0.01% 1274
2020
Q4 		$260K Buy
31,961
+11,149
+54% +$86K 0.01% 981
2020
Q3 		$164K Sell
20,812
-135,364
-87% -$924K 0.01% 750
2020
Q2 		$851K Sell
156,176
-121,521
-44% -$604K 0.05% 348
2020
Q1 		$1.14M Buy
277,697
+149,733
+117% +$874K 0.08% 186
2019
Q4 		$921K Buy
127,964
+54,023
+73% +$334K 0.04% 413
2019
Q3 		$467K Buy
73,941
+18,047
+32% +$115K 0.02% 535
2019
Q2 		$442K Buy
55,894
+19,072
+52% +$148K 0.02% 528
2019
Q1 		$295K Buy
36,822
+11,552
+46% +$80.2K 0.02% 610
2018
Q4 		$155K Buy
+25,270
New +$155K 0.01% 808

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Prelude Capital Management's ETON Position: Q1 2026 in Review

Prelude Capital Management increased its Eton Pharmaceutcials (ETON) stake by 317% in Q1 2026, buying an estimated $2.51M and bringing the position to 188,802 shares worth $4.66M. The position accounts for 0.36% of the portfolio, ranked #58.

Prelude Capital Management first reported a position in ETON in Q4 2018 and has held it in 16 quarters since. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Prelude Capital Management held 188,802 shares of Eton Pharmaceutcials worth $4.66M as of Q1 2026.
  • Prelude Capital Management bought 143,477 Eton Pharmaceutcials shares in Q1 2026, an estimated $2.51M.
  • Eton Pharmaceutcials made up 0.36% of Prelude Capital Management's portfolio in Q1 2026, its #58 holding.
  • Prelude Capital Management first reported a position in Eton Pharmaceutcials in Q4 2018 and has held it in 16 quarters since.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.